Glutathione S-Transferase M1/ T1 Polymorphisms and Schizophrenia Risk: A New Method for Quality Assessment and a Systematic Review
- PMID: 36643584
- PMCID: PMC9833125
- DOI: 10.2147/NDT.S376942
Glutathione S-Transferase M1/ T1 Polymorphisms and Schizophrenia Risk: A New Method for Quality Assessment and a Systematic Review
Abstract
Background: GST genes were reported to be involved in susceptibility to mental disorder. The results between deletions of GST genes and schizophrenia were inconclusive and confusing. Therefore, we performed this updated meta-analysis to outline the association using a new method for quality assessment.
Methods: Sixteen reported studies were selected, and the overall OR and 95% CI were calculated and analyzed by Review Manager 5.4 and STATE 12. The Newcastle-Ottawa Quality Assessment Scale (NOS) for case-control studies was rewritten to evaluate the quality of published studies, as there was no "Exposure" in these studies and other factors should be suggested to assess the quality.
Results: There was no significant association between deletions of GST genes and SZ risk (p > 0.05 in Random model). We also failed to find a significant relation between null genotypes and SZ risk in East Asian population. Based on further analysis of PCR methods, GSTM1 null was weakly associated with SZ risk in 8 studies using multiplex PCR (OR = 1.17, 95% CI = 1.00-1.37, p = 0.05), but GSTT1 null was a protective factor for SZ risk (OR = 0.73, 95% CI = 0.56-0.94, p = 0.02). When stratified by rewritten NOS stars and deductions, GSTM1 null was significantly associated with SZ risk in 9 studies with high quality (OR = 1.24, 95% CI = 1.08-1.43, p = 0.002), and in 10 studies with no deductions (OR = 1.20, 95% CI = 1.05-1.38, p = 0.007).
Conclusion: GSTM1 null genotype may be a genetic risk factor for SZ in studies using multiplex PCR and high-quality studies. However, GSTT1 null might be a protective factor. Besides, we provided a new method for quality assessment and it was useful and should be promoted in further analysis.
Keywords: GSTM1; glutathione S-transferase T1; meta-analysis; polymorphism; schizophrenia.
© 2023 Liu et al.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Association of glutathione S-transferase polymorphisms (GSTM1 and GSTT1) with primary open-angle glaucoma: an evidence-based meta-analysis.Gene. 2013 Sep 10;526(2):80-6. doi: 10.1016/j.gene.2013.05.032. Epub 2013 Jun 4. Gene. 2013. PMID: 23747403 Review.
-
Association between glutathione S-transferase M1/T1 gene polymorphisms and susceptibility to endometriosis: A systematic review and meta-analysis.Exp Ther Med. 2016 May;11(5):1633-1646. doi: 10.3892/etm.2016.3110. Epub 2016 Feb 26. Exp Ther Med. 2016. PMID: 27168783 Free PMC article.
-
Association of GST genetic polymorphisms with the susceptibility to hepatocellular carcinoma (HCC) in Chinese population evaluated by an updated systematic meta-analysis.PLoS One. 2013;8(2):e57043. doi: 10.1371/journal.pone.0057043. Epub 2013 Feb 20. PLoS One. 2013. PMID: 23437305 Free PMC article.
-
Association between glutathione S-transferase gene M1 and T1 polymorphisms and chronic obstructive pulmonary disease risk: A meta-analysis.Clin Genet. 2019 Jan;95(1):53-62. doi: 10.1111/cge.13373. Epub 2018 Jun 10. Clin Genet. 2019. PMID: 29704242
-
Glutathione S-transferase M1 (GSTM1) and glutathione S-transferase T1 (GSTT1) null polymorphisms, smoking, and their interaction in oral cancer: a HuGE review and meta-analysis.Am J Epidemiol. 2011 Apr 15;173(8):847-57. doi: 10.1093/aje/kwq480. Epub 2011 Mar 24. Am J Epidemiol. 2011. PMID: 21436184 Review.
References
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous